Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21948727 | 0.90 | CTSL (0.46) | CTSLCTSBCTSKEPHX2HCRTR2 | |
| SCHEMBL22168426 | 0.86 | CTSL (0.50) | CTSLCTSBCTSKEPHX2HCRTR2 | |
| SCHEMBL18561604 | 0.86 | CTSL (0.46) | CTSLCTSBCTSKEPHX2HCRTR2 | |
| SCHEMBL19445929 | 0.82 | CTSL (0.47) | CTSLCTSBCTSKEPHX2HCRTR2 | |
| SCHEMBL22008361 | 0.79 | CTSL (0.41) | CTSLCTSBCTSKEPHX2HCRTR2 | |
| SCHEMBL13115124 | 0.77 | HCRTR2 (0.39) | CTSLCTSBCTSKHCRTR2 | |
| SCHEMBL28832774 | 0.77 | CTSL (0.57) | CTSLCTSBCTSKEPHX2 | |
| SCHEMBL4346290 | 0.77 | CTSL (0.52) | CTSLCTSBCTSKEPHX2 | |
| SCHEMBL19993173 | 0.76 | ALDH1A1 (0.38) | — | |
| SCHEMBL10091209 | 0.76 | CTSL (0.41) | CTSLCTSBCTSKEPHX2HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306615-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2024-01-17 | — | — | EP | disclosed |
| EP-4261268-A1 | LIQUID CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2023-10-18 | — | — | EP | disclosed |
| EP-4261267-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2023-10-18 | — | — | EP | disclosed |